BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26539288)

  • 1. The function, regulation and therapeutic implications of the tumor suppressor protein, PML.
    Guan D; Kao HY
    Cell Biosci; 2015; 5():60. PubMed ID: 26539288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Promyelocytic Leukemia Nuclear Bodies During HPV Infection.
    Guion LG; Sapp M
    Front Cell Infect Microbiol; 2020; 10():35. PubMed ID: 32154186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PML: Regulation and multifaceted function beyond tumor suppression.
    Hsu KS; Kao HY
    Cell Biosci; 2018; 8():5. PubMed ID: 29416846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional proteomic analysis of promyelocytic leukaemia nuclear bodies in irradiation-induced MCF-7 cells.
    Liu J; Song Y; Tian B; Qian J; Dong Y; Liu J; Liu B; Sun Z
    J Biochem; 2010 Dec; 148(6):659-67. PubMed ID: 20823370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional roles of PML nuclear bodies in genome maintenance.
    Chang HR; Munkhjargal A; Kim MJ; Park SY; Jung E; Ryu JH; Yang Y; Lim JS; Kim Y
    Mutat Res; 2018 May; 809():99-107. PubMed ID: 28521962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-translational Modifications of PML in Regulating the Functions of Nuclear Bodies --Review].
    Ma XF; Tan Y; Li SF; Jin W; Wang KK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1696-1700. PubMed ID: 31607334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound In Vivo Inactivation of Pml and p53 Uncovers a Functional Interaction in Angiosarcoma Suppression.
    Papa A; Cordon-Cardo C; Bernardi R; Pandolfi PP
    Genes Cancer; 2012 Sep; 3(9-10):599-603. PubMed ID: 23486996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body language: the function of PML nuclear bodies in apoptosis regulation.
    Hofmann TG; Will H
    Cell Death Differ; 2003 Dec; 10(12):1290-9. PubMed ID: 12934066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promyelocytic leukemia nuclear body: sites of activity?
    Eskiw CH; Bazett-Jones DP
    Biochem Cell Biol; 2002; 80(3):301-10. PubMed ID: 12123283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nuclear bodies in apoptosis signalling.
    Krieghoff-Henning E; Hofmann TG
    Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
    Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
    Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finding a role for PML in APL pathogenesis: a critical assessment of potential PML activities.
    Strudwick S; Borden KL
    Leukemia; 2002 Oct; 16(10):1906-17. PubMed ID: 12357342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Cellular Functions of Cytoplasmic PML.
    Jin G; Wang YJ; Lin HK
    Front Oncol; 2013; 3():147. PubMed ID: 23761861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies.
    Ruthardt M; Orleth A; Tomassoni L; Puccetti E; Riganelli D; Alcalay M; Mannucci R; Nicoletti I; Grignani F; Fagioli M; Pelicci PG
    Oncogene; 1998 Apr; 16(15):1945-53. PubMed ID: 9591778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML.
    Chan JY; Li L; Fan YH; Mu ZM; Zhang WW; Chang KS
    Biochem Biophys Res Commun; 1997 Nov; 240(3):640-6. PubMed ID: 9398618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of PML-I in reformation of PML nuclear bodies in acute promyelocytic leukemia cells by leptomycin B.
    Wang C; Su L; Shao YM; Chen WZ; Bu N; Hao R; Ma LY; Hussain L; Lu XY; Wang QQ; Naranmandura H
    Toxicol Appl Pharmacol; 2019 Dec; 384():114775. PubMed ID: 31669778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
    Fuchs O; Provazníková D; Peslová G
    Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L
    Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
    Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.